AstraZeneca Archives -

FDA reviews Merck & Co’s Keytruda in new ‘tumour agnostic’ use

Merck & Co’s Keytruda cancer immunotherapy could be set for another indication, which could open up for use

FDA reviews Merck & Co’s Keytruda in new ‘tumour agnostic’ use

https://pharmaphorum.com/news/fda-reviews-merck-cos-keytruda-in-new-tumour-agnostic-use/

AZ, GSK and Cambridge Uni will set up COVID-19 testing centre

A new coronavirus diagnosis laboratory will be set up by AstraZeneca, GlaxoSmithKline and Cambridge University, as the UK

AZ, GSK and Cambridge Uni will set up COVID-19 testing centre

https://pharmaphorum.com/news/az-gsk-and-cambridge-uni-will-set-up-covid-19-testing-centre/

Can we target coronavirus RNA with siRNA drugs?

NEW: RNAi-Based Therapeutics Summit

Can we target coronavirus RNA with siRNA drugs?

https://pharmaphorum.com/events/can-we-target-coronavirus-rna-with-sirna-drugs/

GSK eyes nasal polyps use for Nucala after trial success

GlaxoSmithKline is eyeing another indication for its Nucala (mepolizumab) biologic drug after a phase 3 trial in inflammation

GSK eyes nasal polyps use for Nucala after trial success

https://pharmaphorum.com/news/gsk-eyes-nasal-polyps-use-for-nucala-after-trial-success/

AstraZeneca on expanding its diabetes research franchise

AstraZeneca is hoping to build a strong focus on cardiovascular, renal, and metabolic (CVRM) diseases. Richard Staines spoke

AstraZeneca on expanding its diabetes research franchise

https://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/astrazeneca-takes-on-cvrm/

AZ firms up immuno-oncology imaging deal with ImaginAb

AstraZeneca has expanded its alliance with ImaginAb, an imaging specialist developing imaging agents to increase the efficacy and

AZ firms up immuno-oncology imaging deal with ImaginAb

https://pharmaphorum.com/news/az-firms-up-immuno-oncology-imaging-deal-with-imaginab/

BI opens second branch of digital lab in China

Boehringer Ingelheim has announced that it will open a second branch of its digital lab, BI X, in

BI opens second branch of digital lab in China

https://pharmaphorum.com/news/bi-opens-branch-of-digital-lab-in-china/

FDA approves AZ Imfinzi in new lung cancer use

AstraZeneca has reported a double win after the FDA approved its Imfinzi for a form of lung cancer,

FDA approves AZ Imfinzi in new lung cancer use

https://pharmaphorum.com/news/fda-approves-az-imfinzi-in-new-lung-cancer-use/

AstraZeneca: pharma needs to lead by example on sustainability

Paul Tunnah sat down with AstraZeneca’s vice president of sustainability strategy and engagement Jim Massey to discuss how

AstraZeneca: pharma needs to lead by example on sustainability

https://pharmaphorum.com/views-analysis-sales-marketing/astrazeneca-pharma-needs-to-lead-by-example-on-sustainability/

Trending

AstraZeneca

Hello World

FDA reviews Merck & Co’s Keytruda in new ‘tumour agnostic’ use

AZ, GSK and Cambridge Uni will set up COVID-19 testing centre

Can we target coronavirus RNA with siRNA drugs?

GSK eyes nasal polyps use for Nucala after trial success

AstraZeneca on expanding its diabetes research franchise

AZ firms up immuno-oncology imaging deal with ImaginAb

BI opens second branch of digital lab in China

FDA approves AZ Imfinzi in new lung cancer use

AstraZeneca: pharma needs to lead by example on sustainability

Search

Advanced Search

Trending

AstraZeneca

Hello World